Detalhe da pesquisa
1.
Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo.
Cell Mol Life Sci;
80(10): 298, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37728691
2.
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.
Cancer Immunol Immunother;
70(11): 3167-3181, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33796917
3.
Saponin-based adjuvants enhance antigen cross-presentation in human CD11c+ CD1c+ CD5- CD163+ conventional type 2 dendritic cells.
J Immunother Cancer;
11(8)2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37612044